KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles: 2013-2025

Historic Amortizatization of Intangibles for Ionis Pharmaceuticals (IONS) over the last 13 years, with Sep 2025 value amounting to $5.1 million.

  • Ionis Pharmaceuticals' Amortizatization of Intangibles fell 44.37% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 25.18%. This contributed to the annual value of $37.7 million for FY2024, which is 30.63% up from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Amortizatization of Intangibles stood at $5.1 million, which was down 13.37% from $5.9 million recorded in Q2 2025.
  • Ionis Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $9.9 million during Q2 2024, with a 5-year trough of -$4.8 million in Q2 2021.
  • For the 3-year period, Ionis Pharmaceuticals' Amortizatization of Intangibles averaged around $7.7 million, with its median value being $7.9 million (2023).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first plummeted by 278.81% in 2021, then skyrocketed by 756.85% in 2023.
  • Ionis Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at -$4.3 million in 2021, then surged by 139.50% to $1.7 million in 2022, then surged by 404.40% to $8.5 million in 2023, then increased by 11.32% to $9.4 million in 2024, then tumbled by 44.37% to $5.1 million in 2025.
  • Its Amortizatization of Intangibles was $5.1 million in Q3 2025, compared to $5.9 million in Q2 2025 and $7.1 million in Q1 2025.